These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12637789)

  • 1. In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application.
    Colombo G; Zucchi A; Allegra F; Colombo P; Zani F; Santi P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(2):130-6. PubMed ID: 12637789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin permeation of 5-methoxypsoralen from topical dosage forms.
    Colombo G; Artusi M; Santi P; Colombo P; Bettini R; Zucchi A; Nicoli S
    Drug Dev Ind Pharm; 2003 Feb; 29(2):247-51. PubMed ID: 12648022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
    Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
    Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration.
    Zucchi A; Raho E; Marconi B; Nicoli S; Santini M; Allegra F; Colombo P; Bettini R; Santi P
    J Invest Dermatol; 2001 Aug; 117(2):379-82. PubMed ID: 11511320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene--in vivo study.
    Borowska K; Wołowiec S; Rubaj A; Głowniak K; Sieniawska E; Radej S
    Int J Pharm; 2012 Apr; 426(1-2):280-283. PubMed ID: 22310461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment.
    Anigbogu AN; Williams AC; Barry BW
    J Pharm Pharmacol; 1996 Apr; 48(4):357-66. PubMed ID: 8794983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M; Ros AM
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous penetration of 5-methoxypsoralen in rhesus monkeys.
    Konda S; Maibach HI
    Food Chem Toxicol; 2011 May; 49(5):1092-5. PubMed ID: 21281688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoemulsion containing 8-methoxypsoralen for topical treatment of dermatoses: Development, characterization and ex vivo permeation in porcine skin.
    Oliveira CA; Gouvêa MM; Antunes GR; Freitas ZMF; Marques FFC; Ricci-Junior E
    Int J Pharm; 2018 Aug; 547(1-2):1-9. PubMed ID: 29800737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
    Saïd A; Makki S; Muret P; Humbert P; Millet J
    J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
    Neild VS; Scott LV
    Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
    Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
    Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
    Pham CT; Koo JY
    J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free 5-methoxypsoralen fraction in health and psoriasis: relationship with human serum albumin concentration.
    Muret P; Humbert P; Makki S; Bechtel P; Urien S; Tillement JP
    Arch Dermatol Res; 1993; 285(5):287-90. PubMed ID: 8379689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
    John BA; Chasseaud LF; Wood SG; Forlot P
    Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA in psoriatic epidermis.
    Sondergaard J; Lerche A; Bohr V; Leik V; Wadskov S
    Acta Derm Venereol Suppl (Stockh); 1979; 87():59-63. PubMed ID: 294785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
    Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a microdialysis-gas chromatographic-mass spectrometric method to assess 8-methoxypsoralen in psoriatic patient dermis.
    Leveque N; Muret P; Mary S; Bérard M; Makki S; Pierre Kantelip J; Humbert P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):119-27. PubMed ID: 12383487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.